Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Translational insights into extracellular vesicles in peritoneal dialysis.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same author

Tuning Anticancer Activity and Antimicrobial Response of ZnO Nanoparticles Through Halogenosilane Surface Modification.

International journal of molecular sciences·2026
Same author

Immune (dys)function in obsessive-compulsive disorder.

Brain, behavior, and immunity·2026
Same author

Correction: Probing the photoabsorption features and electronic excited states of propylene oxide: an experimental and theoretical study.

Physical chemistry chemical physics : PCCP·2026
Same author

Integrating green chemistry into SPION development: a theranostic study on prostate cell models.

Nanoscale·2026
Same author

Probing the photoabsorption features and electronic excited states of propylene oxide: an experimental and theoretical study.

Physical chemistry chemical physics : PCCP·2026

Related Experiment Video

Updated: Dec 11, 2025

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.6K

New copper(I) complexes selective for prostate cancer cells.

João Franco Machado1, Diogo Sequeira, Fernanda Marques

  • 1CQE, Centro de Química Estrutural, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, Portugal. tsmorais@fc.ul.pt.

Dalton Transactions (Cambridge, England : 2003)
|August 26, 2020
PubMed
Summary

New copper(I) complexes show potent anticancer activity, particularly against prostate cancer cells. One compound, [Cu(dppe)(2-ap)][BF4] (16), demonstrates significant selectivity and efficacy, making it a promising candidate for prostate cancer research.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.6K
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

58.5K

Related Experiment Videos

Last Updated: Dec 11, 2025

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.6K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.6K
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

58.5K

Area of Science:

  • Coordination Chemistry
  • Medicinal Chemistry
  • Materials Science

Background:

  • Copper(I) complexes are explored for their diverse biological activities.
  • Developing novel metallodrugs with targeted cytotoxicity is a key area in cancer research.

Purpose of the Study:

  • To synthesize and characterize a new series of eighteen copper(I) complexes.
  • To evaluate the in vitro cytotoxicity of these complexes against human breast and prostate cancer cell lines.

Main Methods:

  • Synthesis and full characterization using analytical and spectroscopic methods.
  • Single crystal X-ray diffraction for structural elucidation of five complexes.
  • Cytotoxicity assays (IC50 determination) on MCF7, LNCap, and RWPE cell lines.

Main Results:

  • All synthesized copper(I) complexes exhibited cytotoxicity against tested cancer cell lines.
  • Compounds showed higher efficacy against prostate cancer (LNCap) than breast cancer (MCF7) cells.
  • Complex (16), [Cu(dppe)(2-ap)][BF4], displayed potent and selective cytotoxicity (IC50 0.2-2 μM), with 70-fold higher activity against LNCap cells compared to normal RWPE cells.

Conclusions:

  • The synthesized copper(I) complexes represent a promising class of anticancer agents.
  • Complex (16) shows significant potential for further investigation in prostate cancer therapy due to its high selectivity and efficacy.
  • Further studies should focus on the mechanism of action, including cellular uptake, ROS generation, and apoptosis induction observed for complex (16).